Double Barreled Antibodies Drug
Double Barreled Antibodies Drug market is segmented by region (country), players, by Type and by ... Read More
Global and United States Endometrial Cancer Therapeutics Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Endometrial Cancer Therapeutics Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Endometrial Cancer Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Endometrial Cancer Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Endometrial Cancer Therapeutics Market Size for the Year 2017-2028
1.3 Endometrial Cancer Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Endometrial Cancer Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Endometrial Cancer Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Endometrial Cancer Therapeutics Market Dynamics
1.4.1 Endometrial Cancer Therapeutics Industry Trends
1.4.2 Endometrial Cancer Therapeutics Market Drivers
1.4.3 Endometrial Cancer Therapeutics Market Challenges
1.4.4 Endometrial Cancer Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Endometrial Cancer Therapeutics by Type
2.1 Endometrial Cancer Therapeutics Market Segment by Type
2.1.1 Chemotherapy
2.1.2 Hormone Therapy
2.1.3 Radiation Therapy
2.1.4 Surgery
2.2 Global Endometrial Cancer Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Endometrial Cancer Therapeutics Market Size by Type (2017-2028)
2.4 United States Endometrial Cancer Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Endometrial Cancer Therapeutics Market Size by Type (2017-2028)
3 Endometrial Cancer Therapeutics by Application
3.1 Endometrial Cancer Therapeutics Market Segment by Application
3.1.1 Research Institutes
3.1.2 Hospitals & Clinics
3.2 Global Endometrial Cancer Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Endometrial Cancer Therapeutics Market Size by Application (2017-2028)
3.4 United States Endometrial Cancer Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Endometrial Cancer Therapeutics Market Size by Application (2017-2028)
4 Global Endometrial Cancer Therapeutics Competitor Landscape by Company
4.1 Global Endometrial Cancer Therapeutics Market Size by Company
4.1.1 Top Global Endometrial Cancer Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Endometrial Cancer Therapeutics Revenue by Player (2017-2022)
4.2 Global Endometrial Cancer Therapeutics Concentration Ratio (CR)
4.2.1 Endometrial Cancer Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Endometrial Cancer Therapeutics in 2021
4.2.3 Global Endometrial Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Endometrial Cancer Therapeutics Headquarters, Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Endometrial Cancer Therapeutics Headquarters and Area Served
4.3.2 Global Endometrial Cancer Therapeutics Companies Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Endometrial Cancer Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Endometrial Cancer Therapeutics Market Size by Company
4.5.1 Top Endometrial Cancer Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Endometrial Cancer Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Endometrial Cancer Therapeutics Market Size by Region
5.1 Global Endometrial Cancer Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Endometrial Cancer Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Endometrial Cancer Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Endometrial Cancer Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Endometrial Cancer Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Endometrial Cancer Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Endometrial Cancer Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Endometrial Cancer Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Endometrial Cancer Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Endometrial Cancer Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Endometrial Cancer Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Endometrial Cancer Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Endometrial Cancer Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Endometrial Cancer Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Details
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Endometrial Cancer Therapeutics Introduction
7.1.4 Bayer AG Revenue in Endometrial Cancer Therapeutics Business (2017-2022)
7.1.5 Bayer AG Recent Development
7.2 F. Hoffman La Roche Ltd.
7.2.1 F. Hoffman La Roche Ltd. Company Details
7.2.2 F. Hoffman La Roche Ltd. Business Overview
7.2.3 F. Hoffman La Roche Ltd. Endometrial Cancer Therapeutics Introduction
7.2.4 F. Hoffman La Roche Ltd. Revenue in Endometrial Cancer Therapeutics Business (2017-2022)
7.2.5 F. Hoffman La Roche Ltd. Recent Development
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Company Details
7.3.2 Bristol-Myers Squibb Company Business Overview
7.3.3 Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Introduction
7.3.4 Bristol-Myers Squibb Company Revenue in Endometrial Cancer Therapeutics Business (2017-2022)
7.3.5 Bristol-Myers Squibb Company Recent Development
7.4 Merck KGaA
7.4.1 Merck KGaA Company Details
7.4.2 Merck KGaA Business Overview
7.4.3 Merck KGaA Endometrial Cancer Therapeutics Introduction
7.4.4 Merck KGaA Revenue in Endometrial Cancer Therapeutics Business (2017-2022)
7.4.5 Merck KGaA Recent Development
7.5 Novartis AG
7.5.1 Novartis AG Company Details
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Endometrial Cancer Therapeutics Introduction
7.5.4 Novartis AG Revenue in Endometrial Cancer Therapeutics Business (2017-2022)
7.5.5 Novartis AG Recent Development
7.6 Takeda Pharmaceutical Company Limited
7.6.1 Takeda Pharmaceutical Company Limited Company Details
7.6.2 Takeda Pharmaceutical Company Limited Business Overview
7.6.3 Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Introduction
7.6.4 Takeda Pharmaceutical Company Limited Revenue in Endometrial Cancer Therapeutics Business (2017-2022)
7.6.5 Takeda Pharmaceutical Company Limited Recent Development
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Company Details
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Endometrial Cancer Therapeutics Introduction
7.7.4 Eli Lilly and Company Revenue in Endometrial Cancer Therapeutics Business (2017-2022)
7.7.5 Eli Lilly and Company Recent Development
7.8 Sanofi
7.8.1 Sanofi Company Details
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Endometrial Cancer Therapeutics Introduction
7.8.4 Sanofi Revenue in Endometrial Cancer Therapeutics Business (2017-2022)
7.8.5 Sanofi Recent Development
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Company Details
7.9.2 GlaxoSmithKline plc Business Overview
7.9.3 GlaxoSmithKline plc Endometrial Cancer Therapeutics Introduction
7.9.4 GlaxoSmithKline plc Revenue in Endometrial Cancer Therapeutics Business (2017-2022)
7.9.5 GlaxoSmithKline plc Recent Development
7.10 ArQule, Inc.
7.10.1 ArQule, Inc. Company Details
7.10.2 ArQule, Inc. Business Overview
7.10.3 ArQule, Inc. Endometrial Cancer Therapeutics Introduction
7.10.4 ArQule, Inc. Revenue in Endometrial Cancer Therapeutics Business (2017-2022)
7.10.5 ArQule, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Endometrial Cancer Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Endometrial Cancer Therapeutics Market Trends
Table 3. Endometrial Cancer Therapeutics Market Drivers
Table 4. Endometrial Cancer Therapeutics Market Challenges
Table 5. Endometrial Cancer Therapeutics Market Restraints
Table 6. Global Endometrial Cancer Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Endometrial Cancer Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Endometrial Cancer Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Endometrial Cancer Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Endometrial Cancer Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Endometrial Cancer Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Endometrial Cancer Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Endometrial Cancer Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Endometrial Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometrial Cancer Therapeutics as of 2021)
Table 15. Top Players of Endometrial Cancer Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Endometrial Cancer Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Endometrial Cancer Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Endometrial Cancer Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Endometrial Cancer Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Endometrial Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Endometrial Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Endometrial Cancer Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Endometrial Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Endometrial Cancer Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Endometrial Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Endometrial Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Endometrial Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Bayer AG Company Details
Table 31. Bayer AG Business Overview
Table 32. Bayer AG Endometrial Cancer Therapeutics Product
Table 33. Bayer AG Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Bayer AG Recent Development
Table 35. F. Hoffman La Roche Ltd. Company Details
Table 36. F. Hoffman La Roche Ltd. Business Overview
Table 37. F. Hoffman La Roche Ltd. Endometrial Cancer Therapeutics Product
Table 38. F. Hoffman La Roche Ltd. Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 39. F. Hoffman La Roche Ltd. Recent Development
Table 40. Bristol-Myers Squibb Company Company Details
Table 41. Bristol-Myers Squibb Company Business Overview
Table 42. Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Product
Table 43. Bristol-Myers Squibb Company Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Bristol-Myers Squibb Company Recent Development
Table 45. Merck KGaA Company Details
Table 46. Merck KGaA Business Overview
Table 47. Merck KGaA Endometrial Cancer Therapeutics Product
Table 48. Merck KGaA Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Merck KGaA Recent Development
Table 50. Novartis AG Company Details
Table 51. Novartis AG Business Overview
Table 52. Novartis AG Endometrial Cancer Therapeutics Product
Table 53. Novartis AG Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Novartis AG Recent Development
Table 55. Takeda Pharmaceutical Company Limited Company Details
Table 56. Takeda Pharmaceutical Company Limited Business Overview
Table 57. Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Product
Table 58. Takeda Pharmaceutical Company Limited Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Takeda Pharmaceutical Company Limited Recent Development
Table 60. Eli Lilly and Company Company Details
Table 61. Eli Lilly and Company Business Overview
Table 62. Eli Lilly and Company Endometrial Cancer Therapeutics Product
Table 63. Eli Lilly and Company Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Eli Lilly and Company Recent Development
Table 65. Sanofi Company Details
Table 66. Sanofi Business Overview
Table 67. Sanofi Endometrial Cancer Therapeutics Product
Table 68. Sanofi Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Sanofi Recent Development
Table 70. GlaxoSmithKline plc Company Details
Table 71. GlaxoSmithKline plc Business Overview
Table 72. GlaxoSmithKline plc Endometrial Cancer Therapeutics Product
Table 73. GlaxoSmithKline plc Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 74. GlaxoSmithKline plc Recent Development
Table 75. ArQule, Inc. Company Details
Table 76. ArQule, Inc. Business Overview
Table 77. ArQule, Inc. Endometrial Cancer Therapeutics Product
Table 78. ArQule, Inc. Revenue in Endometrial Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 79. ArQule, Inc. Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Endometrial Cancer Therapeutics Product Picture
Figure 2. Global Endometrial Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Endometrial Cancer Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Endometrial Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Endometrial Cancer Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Endometrial Cancer Therapeutics Market Share in Global 2017-2028
Figure 7. Endometrial Cancer Therapeutics Report Years Considered
Figure 8. Product Picture of Chemotherapy
Figure 9. Product Picture of Hormone Therapy
Figure 10. Product Picture of Radiation Therapy
Figure 11. Product Picture of Surgery
Figure 12. Global Endometrial Cancer Therapeutics Market Share by Type in 2022 & 2028
Figure 13. Global Endometrial Cancer Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Endometrial Cancer Therapeutics Market Share by Type (2017-2028)
Figure 15. United States Endometrial Cancer Therapeutics Market Share by Type in 2022 & 2028
Figure 16. United States Endometrial Cancer Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Endometrial Cancer Therapeutics Market Share by Type (2017-2028)
Figure 18. Product Picture of Research Institutes
Figure 19. Product Picture of Hospitals & Clinics
Figure 20. Global Endometrial Cancer Therapeutics Market Share by Application in 2022 & 2028
Figure 21. Global Endometrial Cancer Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Endometrial Cancer Therapeutics Market Share by Application (2017-2028)
Figure 23. United States Endometrial Cancer Therapeutics Market Share by Application in 2022 & 2028
Figure 24. United States Endometrial Cancer Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Endometrial Cancer Therapeutics Market Share by Application (2017-2028)
Figure 26. North America Endometrial Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Endometrial Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Endometrial Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Taiwan Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Philippines Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Endometrial Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Endometrial Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.A.E Endometrial Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Bayer AG Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2017-2022)
Figure 55. F. Hoffman La Roche Ltd. Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2017-2022)
Figure 56. Bristol-Myers Squibb Company Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2017-2022)
Figure 57. Merck KGaA Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2017-2022)
Figure 58. Novartis AG Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2017-2022)
Figure 59. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2017-2022)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2017-2022)
Figure 61. Sanofi Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2017-2022)
Figure 62. GlaxoSmithKline plc Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2017-2022)
Figure 63. ArQule, Inc. Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer AG F. Hoffman La Roche Ltd. Bristol-Myers Squibb Company Merck KGaA Novartis AG Takeda Pharmaceutical Company Limited Eli Lilly and Company Sanofi GlaxoSmithKline plc ArQule, Inc.